EVFM stock forecast
Our latest prediction for Evofem Biosciences, Inc.'s stock price was made on the Jan. 13, 2020 when the stock price was at 6.09$.
In the short term (2weeks), EVFM's stock price should underperform the market by -6.20%. During that period the price should oscillate between -10.69% and +11.95%.
In the medium term (3months), EVFM's stock price should underperform the market by -7.20%. During that period the price should oscillate between -45.87% and +26.80%.Get email alerts
About Evofem Biosciences, Inc.
Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.19$ per share.
The book value per share is 0.20$
Three months stock forecastJan. 13, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|